W Häuser1, K Bernardy, H Wang, I Kopp. 1. Innere Medizin 1, Klinikum Saarbrücken gGmbH, Winterberg 1, 66119, Saarbrücken, Deutschland. whaeuser@klinikum-saarbruecken.de
Abstract
BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. Efficacy, risks, patient preferences and applicability of therapies available were summarized into a balance sheet. The guidelines were reviewed by the boards of the participating scientific medical societies. CONCLUSION: The guidelines were published in several forms: complete and short scientific versions, clinical practice and patient versions. The English full-text version of this article is available at SpringerLink (under "Supplemental").
BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. Efficacy, risks, patient preferences and applicability of therapies available were summarized into a balance sheet. The guidelines were reviewed by the boards of the participating scientific medical societies. CONCLUSION: The guidelines were published in several forms: complete and short scientific versions, clinical practice and patient versions. The English full-text version of this article is available at SpringerLink (under "Supplemental").
Authors: Andrew R Moore; Christopher Eccleston; Sheena Derry; Phillip Wiffen; Rae F Bell; Sebastian Straube; Henry McQuay Journal: Pain Date: 2010-06-02 Impact factor: 6.961
Authors: Lucie Brosseau; George A Wells; Peter Tugwell; Mary Egan; Keith G Wilson; Claire-Jehanne Dubouloz; Lynn Casimiro; Vivian A Robinson; Jessie McGowan; Angela Busch; Stéphane Poitras; Harvey Moldofsky; Manfred Harth; Hillel M Finestone; Warren Nielson; Angela Haines-Wangda; Marion Russell-Doreleyers; Kim Lambert; Alison D Marshall; Line Veilleux Journal: Phys Ther Date: 2008-05-22
Authors: J Rivera; C Alegre; F J Ballina; J Carbonell; L Carmona; B Castel; A Collado; J J Esteve; F G Martínez; J Tornero; M A Vallejo; J Vidal Journal: Reumatol Clin Date: 2008-12-10
Authors: C Alegre de Miquel; J García Campayo; M Tomás Flórez; J M Gómez Arguelles; E Blanco Tarrio; M Gobbo Montoya; Á Pérez Martin; A Martínez Salio; J Vidal Fuentes; E Altarriba Alberch; A Gómez de la Cámara Journal: Actas Esp Psiquiatr Date: 2010 Mar-Apr Impact factor: 1.196
Authors: S F Carville; L Arendt-Nielsen; S Arendt-Nielsen; H Bliddal; F Blotman; J C Branco; D Buskila; J A P Da Silva; B Danneskiold-Samsøe; F Dincer; C Henriksson; K G Henriksson; E Kosek; K Longley; G M McCarthy; S Perrot; M Puszczewicz; P Sarzi-Puttini; A Silman; M Späth; E H Choy Journal: Ann Rheum Dis Date: 2007-07-20 Impact factor: 19.103
Authors: Mary-Ann Fitzcharles; Yoram Shir; Jacob N Ablin; Dan Buskila; Howard Amital; Peter Henningsen; Winfried Häuser Journal: Evid Based Complement Alternat Med Date: 2013-11-26 Impact factor: 2.629
Authors: Robert Michael Cronin; Tilicia L Mayo-Gamble; Sarah-Jo Stimpson; Sherif M Badawy; Lori E Crosby; Jeannie Byrd; Emmanuel J Volanakis; Adetola A Kassim; Jean L Raphael; Velma M Murry; Michael R DeBaun Journal: BMC Hematol Date: 2018-06-08